, Ongoing analysis 2.6. Cryptococcal meningitis: outcome beyond ten weeks of initial treatment 2.6.1. Draft article 6, vol.5

F. Sanfelice, Contributo alla morfologia e biologia dei blastomiceti che si sviluppano nei succhi di alcuni frutti. Ann Igien, 1894, vol.4, pp.463-495

O. Busse and U. Parasitare-zelleinschlusse-und-ihre-zuchtung, Zentralbl Bakteriol, vol.16, pp.175-180, 1894.

. Kwon-chung, . Kj, J. A. Fraser, . Doering, . Tl et al., Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med, vol.4, p.19760, 2014.

P. Vuillemin and L. Blastomycètes-pathogènes, Rev Gen Sci Pures Appl, vol.12, pp.732-751, 1901.

M. Versé, Über einen Fall von generalisierter Blastomykose beim Menschen. Verh. dtsch. path. Ges, p.275, 1914.

. Stoddard, E. C. Cutler, and T. , Infection in Man: A Group of Cases, Characterized by Chronic Lesions of the Central Nervous System, with Clinical Symptoms Suggestive of Cerebral Tumor, Produced by an Organism Belonging to the Torula Group (Torula Histolytica, N. Sp.), 1916.

C. W. Emmons, Isolation of Cryptococcus neoformans from soil, J Bacteriol, vol.62, issue.6, pp.685-90, 1951.

E. E. Evans, The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular and agglutination reactions, J Immunol, vol.64, issue.5, pp.423-453, 1950.

D. E. Wilson, J. E. Bennett, . Bailey, and . Jw, Serologic grouping of Cryptococcus neoformans, Proc Soc Exp Biol Med, vol.127, issue.3, pp.820-823, 1968.

. Kwon-chung, . Kj, I. Polacheck, . Bennett, and . Je, Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C), J Clin Microbiol, vol.15, issue.3, pp.535-542, 1982.

S. P. Franzot, I. F. Salkin, and A. Casadevall, Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates, J Clin Microbiol, vol.37, issue.3, pp.838-878, 1999.

. Kwon-chung, . Kj, T. Boekhout, J. W. Fell, and M. Diaz, 1557) Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae), Taxon, vol.51, issue.4, pp.804-806, 2002.

P. Ngamskulrungroj, F. Gilgado, J. Faganello, A. P. Litvintseva, A. L. Leal et al., Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties, PLoS One, vol.4, issue.6, p.5862, 2009.

M. Cogliati, Global Molecular Epidemiology of Cryptococcus neoformans and Cryptococcus gattii: An Atlas of the Molecular Types. Scientifica (Cairo), p.675213, 2013.

F. Hagen, K. Khayhan, B. Theelen, A. Kolecka, I. Polacheck et al., Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex, Fungal Genetics and Biology, vol.78, pp.16-48, 2015.

. Kwon-chung, . Kj, J. E. Bennett, . Wickes, . Bl et al., The Case for Adopting the

R. C. May, . Stone, . Nr, . Wiesner, . Dl et al., Cryptococcus: from environmental saprophyte to global pathogen, Nat Rev Microbiol, vol.14, issue.2, pp.106-123, 2016.

F. Brito-santos, . Barbosa, . Gg, L. Trilles, . Nishikawa et al., Environmental isolation of Cryptococcus gattii VGII from indoor dust from typical wooden houses in the deep Amazonas of the Rio Negro basin, PLoS One, vol.10, issue.2, p.115866, 2015.

D. J. Springer, . Billmyre, . Rb, . Filler, . Ee et al., Cryptococcus gattii VGIII isolates causing infections in HIV/AIDS patients in Southern California: identification of the local environmental source as arboreal, PLoS pathogens, vol.10, issue.8, p.1004285, 2014.

A. Chowdhary, . Rhandhawa, . Hs, A. Prakash, . Meis et al., Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update, Crit Rev Microbiol, vol.38, issue.1, pp.1-16, 2012.

A. P. Litvintseva, I. Carbone, J. Rossouw, R. Thakur, N. P. Govender et al., Evidence that the human pathogenic fungus Cryptococcus neoformans var. grubii may have evolved in Africa, PLoS One, vol.6, issue.5, p.19688, 2011.

Z. Khan, M. Pal, H. Randhawa, R. Sandhu, and C. Of, Cryptococcus neoformans in the crops of pigeons, Journal of medical microbiology, vol.11, issue.2, pp.215-218, 1978.

D. L. Goldman, H. Khine, J. Abadi, . Lindenberg, . Dj et al., Serologic evidence for Cryptococcus neoformansinfection in early childhood, Pediatrics, vol.107, issue.5, pp.66-66, 2001.

K. L. Wozniak, J. M. Vyas, . Levitz, and . Sm, In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis, Infect Immun, vol.74, issue.7, pp.3817-3841, 2006.

S. K. Bauman, G. B. Huffnagle, . Murphy, and . Jw, Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response, Infect Immun, vol.71, issue.1, pp.68-74, 2003.

M. A. Kleinschek, U. Muller, N. Schutze, R. Sabat, . Straubinger et al., Administration of IL-23 engages innate and adaptive immune mechanisms during fungal infection, Int Immunol, vol.22, issue.2, pp.81-90, 2010.

S. M. Levitz, . Nong, . Sh, . Seetoo, . Kf et al., Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages, Infect Immun, vol.67, issue.2, pp.885-90, 1999.

Y. Zhang, F. Wang, . Tompkins, . Kc, A. Mcnamara et al., Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. The American journal of pathology, vol.175, pp.2489-2500, 2009.

S. Arora, Y. Hernandez, . Erb-downward, . Jr, . Mcdonald et al., Role of IFN-? in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis, The Journal of Immunology, vol.174, issue.10, pp.6346-6356, 2005.

U. Müller, W. Stenzel, G. Köhler, C. Werner, T. Polte et al., IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans, The Journal of Immunology, vol.179, issue.8, pp.5367-5377, 2007.

F. Dromer, A. Casadevall, J. Perfect, and T. Sorrell, Cryptococcus neoformans: latency and disease, in Cryptococcus, pp.431-439, 2011.

A. A. Siddiqui, A. E. Brouwer, V. Wuthiekanun, S. Jaffar, R. Shattock et al., IFNgamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis, J Immunol, vol.174, issue.3, pp.1746-50, 2005.

J. N. Jarvis, G. Meintjes, T. Bicanic, V. Buffa, L. Hogan et al., Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis, PLoS Pathog, vol.11, issue.4, p.1004754, 2015.

T. Schoffelen, M. Illnait-zaragozi, L. A. Joosten, . Netea, . Mg et al., Cryptococcus gattii induces a cytokine pattern that is distinct from other cryptococcal species, PloS one, vol.8, issue.1, p.55579, 2013.

M. Piccioni, C. Monari, S. Kenno, E. Pericolini, E. Gabrielli et al., A purified capsular polysaccharide markedly inhibits inflammatory response during endotoxic shock, Infection and immunity, vol.81, issue.1, pp.90-98, 2013.

P. Angkasekwinai, N. Sringkarin, O. Supasorn, M. Fungkrajai, Y. Wang et al., Cryptococcus gattii infection dampens Th1 and Th17 responses by attenuating dendritic cell function and pulmonary chemokine expression in the immunocompetent hosts, Infection and immunity, vol.82, issue.9, pp.3880-3890, 2014.

. Tucker and A. Casadevall, Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm, Proceedings of the National Academy of Sciences, vol.99, pp.3165-3170, 2002.

C. Coelho, A. L. Bocca, and A. Casadevall, The intracellular life of Cryptococcus neoformans, Annu Rev Pathol, vol.9, pp.219-257, 2014.

K. Voelz, D. A. Lammas, . May, and . Rc, Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans, Infection and immunity, vol.77, issue.8, pp.3450-3457, 2009.

L. M. Smith, E. F. Dixon, . May, and . Rc, The fungal pathogen Cryptococcus neoformans manipulates macrophage phagosome maturation. Cellular microbiology, vol.17, pp.702-713, 2015.

. Alvarez and A. Casadevall, Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages, Current Biology, vol.16, issue.21, pp.2161-2165, 2006.

A. Alanio, F. Vernel-pauillac, A. Sturny-leclere, and F. Dromer, Cryptococcus neoformans host adaptation: toward biological evidence of dormancy, MBio, issue.6, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-01405218

K. Vu, R. Tham, . Uhrig, . Jp, N. Thompson et al., Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease, MBio, vol.5, issue.3, pp.1101-1115, 2014.

A. Jong, C. H. Wu, N. V. Prasadarao, . Kwon-chung, . Kj et al., Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells requires protein kinase C-alpha activation, Cell Microbiol, vol.10, issue.9, pp.1854-65, 2008.

C. Charlier, K. Nielsen, S. Daou, M. Brigitte, F. Chretien et al., Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans, Infect Immun, vol.77, issue.1, pp.120-127, 2009.

V. Pyrgos, A. E. Seitz, . Steiner, . Ca, D. R. Prevots et al., Epidemiology of cryptococcal meningitis in the, PLoS One, vol.8, issue.2, p.56269, 2013.

P. G. Pappas, . Perfect, . Jr, . Cloud, . Ga et al., Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy, Clin Infect Dis, vol.33, issue.5, pp.690-699, 2001.

P. G. Pappas, A. Bd, . Andes, . Dr, S. Hadley et al., Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET), Clin Infect Dis, vol.50, issue.8, pp.1101-1112, 2010.

F. Lanternier, S. Cypowyj, C. Picard, J. Bustamante, O. Lortholary et al., Primary immunodeficiencies underlying fungal infections, Curr Opin Pediatr, vol.25, issue.6, pp.736-783, 2013.

F. Dromer, S. Mathoulin-pelissier, A. Fontanet, O. Ronin, B. Dupont et al., Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre-and post-HAART eras, AIDS, vol.18, issue.3, pp.555-62, 2004.

J. N. Jarvis, G. Meintjes, A. Williams, Y. Brown, T. Crede et al., Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases, BMC Infect Dis, vol.10, p.67, 2010.

R. Rajasingham, . Smith, . Park, . Bj, . Jarvis et al., Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis, Lancet Infect Dis, vol.17, issue.8, pp.873-881, 2017.

M. W. Tenforde, M. Mokomane, T. Leeme, . Patel, . Rkk et al., Advanced HIV disease in Botswana following successful antiretroviral therapy rollout: Incidence of and temporal trends in cryptococcal meningitis, Clin Infect Dis, vol.16, issue.7, pp.1031-1039, 2002.

D. Meya, R. Rajasingham, E. Nalintya, M. Tenforde, . Jarvis et al., Preventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy, Curr Trop Med Rep, vol.2, issue.2, pp.81-89, 2015.

J. N. Jarvis, . Lawn, . Sd, M. Vogt, N. Bangani et al., Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa, Clin Infect Dis, vol.48, issue.7, pp.856-62, 2009.

B. J. Park, K. A. Wannemuehler, . Marston, . Bj, N. Govender et al., Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS, AIDS, vol.23, issue.4, pp.525-555, 2009.

, Fact sheet -Latest statistics on the status of the AIDS epidemic, p.23, 2017.

F. Dromer, S. Mathoulin-pelissier, O. Launay, O. Lortholary, F. C. Study et al., Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study, PLoS Med, vol.4, issue.2, p.21, 2007.

J. N. Jarvis, H. Wainwright, . Harrison, R. Ts, K. Meintjes et al., Pulmonary cryptococcosis misdiagnosed as smear-negative pulmonary tuberculosis with fatal consequences, Int J Infect Dis, vol.14, pp.310-312, 2010.

M. L. Wong, P. Back, . Candy, G. Nelson, and J. Murray, Cryptococcal pneumonia in African miners at autopsy, Int J Tuberc Lung Dis, vol.11, issue.5, pp.528-561, 2007.

S. C. Chen, M. A. Slavin, . Heath, . Ch, . Playford et al., Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death, Clin Infect Dis, vol.55, issue.6, pp.789-98, 2012.

L. Picon, L. Vaillant, T. Duong, G. Lorette, Y. Bacq et al., Cutaneous cryptococcosis resembling molluscum contagiosum: a first manifestation of AIDS, Acta Derm Venereol, vol.69, issue.4, pp.365-372, 1989.

H. N. Luma, E. Temfack, . Halle, . Mp, . Tchaleu et al., Cryptococcal meningoencephalitis in human immunodeficiency virus/acquired immunodeficiency syndrome in douala, cameroon: a cross sectional study, N Am J Med Sci, issue.5, pp.486-91, 2013.

P. R. Williamson, . Jarvis, . Fisher, . Mc, . Molloy et al., Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy, Nat Rev Neurol, vol.13, issue.1, pp.13-24, 2017.

A. Loyse, A. Moodley, P. Rich, . Molloy, . Sf et al., Neurological, visual, and MRI brain scan findings in 87 South African patients with HIV-associated cryptococcal meningoencephalitis, J Infect, vol.70, issue.6, pp.668-75, 2015.

A. Moodley, W. Rae, A. Bhigjee, C. Connolly, N. Devparsad et al., Early clinical and subclinical visual evoked potential and Humphrey's visual field defects in cryptococcal meningitis, PloS one, vol.7, issue.12, p.52895, 2012.

D. R. Boulware, M. A. Rolfes, R. Rajasingham, V. Hohenberg, M. Qin et al., Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast, Emerg Infect Dis, vol.20, issue.1, pp.45-53, 2014.

A. Kambugu, . Meya, J. Db,-rhein, M. O'brien, . Janoff et al., Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy, Clin Infect Dis, vol.46, issue.11, pp.1694-701, 2008.

D. Pauw, B. Walsh, . Tj, J. P. Donnelly, . Stevens et al., Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, Clin Infect Dis, vol.46, issue.12, pp.1813-1834, 2008.

F. Brito-santos, . Ferreira, . Mf, L. Trilles, M. M. Muniz et al., ): p. e0005304. 72. WHO Rapid Advice. Diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents, and children, PLoS Negl Trop Dis, vol.11, issue.5, 2011.

L. W. Chang, . Phipps, . Wt, G. E. Kennedy, . Rutherford et al., Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV, Cochrane Database Syst Rev, issue.3, p.4773, 2005.

A. Loyse, F. Dromer, J. Day, O. Lortholary, . Harrison et al., Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal, J Antimicrob Chemother, vol.68, issue.11, pp.2435-2479, 2013.

S. Meiring, F. Smidt, M. Kularatne, R. Dawood, H. Govender et al., Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa, PLoS Negl Trop Dis, vol.10, issue.7, p.4865, 2016.

D. R. Boulware, . Meya, . Db, C. Muzoora, M. A. Rolfes et al., Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis, N Engl J Med, vol.370, issue.26, pp.2487-98, 2014.

J. R. Graybill, J. Sobel, M. Saag, . Van-der, C. Horst et al., Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups, Clin Infect Dis, vol.30, issue.1, pp.47-54, 2000.

R. D. Fessler, J. Sobel, L. Guyot, L. Crane, J. Vazquez et al., Management of elevated intracranial pressure in patients with Cryptococcal meningitis, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.17, issue.2, pp.137-142, 1998.

L. Garvey, A. Winston, J. Walsh, F. Post, K. Porter et al., HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era, European journal of neurology, vol.18, issue.3, pp.527-534, 2011.

E. Letang, . Muller, . Mc, A. J. Ntamatungiro, N. Kimera et al., Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality. Open Forum Infect Dis, vol.2, p.46, 2015.

B. Morawski, D. Boulware, E. Nalintya, A. Kiragga, F. Kazooza et al., Preart cryptococcal antigen titer associated with preemptive fluconazole failure, Conference on Retroviruses and Opportunistic Infections, p.64, 2016.

N. Longley, . Jarvis, . Jn, G. Meintjes, A. Boulle et al., Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study, Clin Infect Dis, vol.62, issue.5, pp.581-587, 2016.

S. Mfinanga, D. Chanda, ,. Kivuyo, . Sl, L. Guinness et al., Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial, Lancet, vol.385, issue.9983, pp.2173-82, 2015.

. Chuck and M. A. Sande, Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome, N Engl J Med, vol.321, issue.12, pp.794-803, 1989.

J. E. Vidal, . Oliveira, . Acp, R. F. Dauar, . Boulware et al., Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America, Brazilian Journal of Infectious Diseases, vol.17, issue.3, pp.353-362, 2013.

T. Bicanic, Determinants of acute outcome and long-term survival in HIV-associated cryptococcal meningitis: Results from a combined cohort of 523 patients. Abstract #892, 18th Conference on Retroviruses and Opportunistic Infections, 2011.

J. Katchanov, V. Kleist, M. Arasteh, K. Stocker, and H. , Time-to-amphotericin B' in cryptococcal meningitis in a European low-prevalence setting: analysis of diagnostic delays, QJM, vol.107, issue.10, pp.799-803, 2014.

K. M. Gaskell, C. Rothe, R. Gnanadurai, P. Goodson, C. Jassi et al., A prospective study of mortality from cryptococcal meningitis following treatment induction with 1200 mg oral fluconazole in, PLoS One, vol.9, issue.11, p.110285, 2014.

C. Rothe, . Sloan, . Dj, P. Goodson, J. Chikafa et al., A prospective longitudinal study of the clinical outcomes from cryptococcal meningitis following treatment induction with 800 mg oral fluconazole in, PLoS One, vol.8, issue.6, p.67311, 2013.

K. Ngouana, T. Dongtsa, J. Kouanfack, C. Tonfack, C. Fomena et al., Cryptoccocal meningitis in Yaounde (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole, J Mycol Med, vol.25, issue.1, pp.11-17, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02157606

H. N. Luma, . Tchaleu, . Bc, E. Temfack, . Doualla et al., HIVAssociated Central Nervous System Disease in Patients Admitted at the Douala General Hospital between 2004 and 2009: A Retrospective Study, AIDS Res Treat, p.709810, 2013.

, A phase III, randomised, controlled trial for the treatment of HIV-associated cryptococcal meningitis: oral fluconazole plus flucytosine or one week amphotericin Bbased therapy vs two weeks amphotericin B-based therapy, Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS (PreCASA, 2013.

D. Neofytos, J. A. Fishman, D. Horn, E. Anaissie, C. H. Chang et al., Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients, Transpl Infect Dis, vol.12, issue.3, pp.220-229, 2010.

D. Sow, ,. Tine, . Rc, K. Sylla, M. Djiba et al., Cryptococcal meningitis in Senegal: epidemiology, laboratory findings, therapeutic and outcome of cases diagnosed from, Mycopathologia, vol.176, issue.5-6, pp.443-452, 2004.

S. A. Mirza, M. Phelan, D. Rimland, E. Graviss, R. Hamill et al., The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, Clin Infect Dis, vol.36, issue.6, pp.789-94, 1992.

S. D. Lawn, . Harries, . Ad, X. Anglaret, L. Myer et al., Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa, AIDS, vol.22, issue.15, pp.1897-908, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00266588

A. L. Leal, J. Faganello, A. M. Fuentefria, . Boldo, . Jt et al., Epidemiological profile of cryptococcal meningitis patients in Rio Grande do Sul, Brazil. Mycopathologia, vol.166, pp.71-76, 2008.

S. Bamba, O. Lortholary, A. Sawadogo, A. Millogo, R. T. Guiguemde et al., Decreasing incidence of cryptococcal meningitis in West Africa in the era of highly active antiretroviral therapy, AIDS, vol.26, issue.8, pp.1039-1080, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00712194

R. Mdodo, K. Brown, E. Omonge, W. Jaoko, J. Baddley et al., The prevalence, clinical features, risk factors and outcome associated with cryptococcal meningitis in HIV positive patients in Kenya, East Afr Med J, vol.87, issue.12, pp.481-488, 2010.

, World Health Organisation, Essential prevention and care interventions for adults and adolescents living with HIV in resource-limited settings, 2008.

, Rapid Advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. WHO, 2011. 103. IMMY. CrAg LFA, World Health Organisation, p.17, 2017.

S. W. Kapoor, K. A. Magambo, . Kalluvya, . Se, . Fitzgerald et al., Sixmonth outcomes of HIV-infected patients given short-course fluconazole therapy for asymptomatic cryptococcal antigenemia, AIDS, vol.29, issue.18, pp.2473-2481, 2015.

D. B. Meya, Y. C. Manabe, B. Castelnuovo, . Cook, . Ba et al., Costeffectiveness of serum cryptococcal antigen screening to prevent deaths among HIVinfected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings, Clin Infect Dis, vol.51, issue.4, pp.448-55, 2010.

R. Micol, A. Tajahmady, O. Lortholary, S. Balkan, C. Quillet et al., Costeffectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia, PLoS One, vol.5, issue.11, p.13856, 2010.

J. N. Jarvis, . Harrison, . Ts, . Lawn, . Sd et al., Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa, PLoS One, vol.8, issue.7, p.69288, 2013.

R. M. Smith, T. A. Nguyen, . Ha, . Ht, . Thang et al., Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam, PLoS One, vol.8, issue.4, p.62213, 2013.

, Prise en charge du VIH -Recommandations du groupe d'experts, CNS, 2017.

, The Joanna Briggs Institute, Joanna Briggs Institute Reviewers' Manual: 2016 edition. Australia: The, 2016.

, The Nordic Cochrane Centre. The Cochrane Collaboration, Review Manager (Revman). Version, vol.5, issue.3, 2014.

P. Desmet, K. D. Kayembe, D. Vroey, and C. , The value of cryptococcal serum antigen screening among HIV-positive/AIDS patients in Kinshasa, Zaire. AIDS, vol.3, issue.2, pp.77-85, 1989.

C. A. Liechty, P. Solberg, W. Were, . Ekwaru, . Jp et al., Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda, Trop Med Int Health, vol.12, issue.8, pp.929-964, 2007.

P. Pongsai, K. Atamasirikul, and S. Sungkanuparph, The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts, J Infect, vol.60, issue.6, pp.474-481, 2010.

Y. Mamoojee, S. Shakoor, . Gorton, . Rl, S. Sarfo et al., Short Communication: Low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana, Trop Med Int Health, vol.16, issue.1, pp.53-59, 2011.

L. Linares, J. Paz, and B. Bustamante, Cryptococcal antigenemia in HIV infected patients with a CD4 count ? 100 cell mm-3, in Mycoses, pp.206-207, 2012.

F. Osazuwa, J. O. Dirisu, P. E. Okuonghae, and O. Ugbebor, Screening for cryptococcal antigenemia in anti-retroviral naive AIDS patients in benin city, Nigeria, vol.27, pp.228-259, 2012.

A. R. Ganiem, A. R. Indrati, R. Wisaksana, H. Meijerink, A. Van-der-ven et al., Asymptomatic cryptococcal antigenemia is associated with mortality among HIVpositive patients in Indonesia, J Int AIDS Soc, vol.17, p.18821, 2014.

J. Mckenney, . Smith, . Chiller, . Tm, R. Detels et al., Prevalence and correlates of cryptococcal antigen positivity among AIDS patients--United States, MMWR Morb Mortal Wkly Rep, vol.63, issue.27, pp.585-592, 1986.

. Manabe and R. D. Moore, Cryptococcal Antigen Screening and Preemptive Treatment in a US Cohort of Patients With AIDS, Clin Infect Dis, vol.61, issue.10, pp.1632-1636, 2015.

L. Pac, . Horwitz, . Mm, A. M. Namutebi, . Auerbach et al., Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia, J Acquir Immune Defic Syndr, vol.68, issue.5, pp.69-76, 2015.

C. Chipungu, J. A. Veltman, P. Jansen, P. Chiliko, C. Lossa et al., Feasibility and Acceptability of Cryptococcal Antigen Screening and Prevalence of Cryptocococcemia in Patients Attending a Resource-Limited HIV/AIDS Clinic in Malawi, J Int Assoc Provid AIDS Care, vol.14, issue.5, pp.387-90, 2015.

S. Vallabhaneni, N. Longley, . Smith, . Smith, M. Osler et al., Implementation and Operational Research: Evaluation of a Public-Sector, Provider-Initiated Cryptococcal Antigen Screening and Treatment Program, J Acquir Immune Defic Syndr, vol.72, issue.2, pp.37-42, 2016.

E. E. Ezeanolue, C. Nwizu, . Greene, . Gs, O. Amusu et al., Brief Report: Geographical Variation in Prevalence of Cryptococcal Antigenemia Among HIV-Infected, Treatment-Naive Patients in Nigeria: A Multicenter Cross-Sectional Study, J Acquir Immune Defic Syndr, vol.73, issue.1, pp.117-138, 2016.

Y. C. Manabe, . Nonyane, . Ba, L. Nakiyingi, O. Mbabazi et al., Point-ofcare lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda, PLoS One, vol.9, issue.7, 2014.

. Jackson, C. M. Horst, and . Commentary, Cryptococcosis in AIDS: New Data but Questions Remain, vol.62, pp.588-597, 2016.

J. Vandepitte, R. Verwilghen, P. Zachee, and . Zaire, Lancet, vol.1, issue.8330, pp.925-931, 1977.

R. M. Levy, D. E. Bredesen, . Rosenblum, and . Ml, Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature, J Neurosurg, vol.62, issue.4, pp.475-95, 1985.

D. C. Tanner, . Weinstein, . Mp, B. Fedorciw, . Joho et al., Comparison of commercial kits for detection of cryptococcal antigen, J Clin Microbiol, vol.32, issue.7, pp.1680-1684, 1994.

A. Temstet, P. Roux, . Poirot, . Jl, O. Ronin et al., Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies, J Clin Microbiol, vol.30, issue.10, pp.2544-50, 1992.

N. Bloomfield, M. A. Gordon, . Elmendorf, and J. Df, Detection of Cryptococcus Neoformans Antigen in Body Fluids by Latex Particle Agglutination, Proc Soc Exp Biol Med, vol.114, pp.64-71, 1963.

. Diamond and J. E. Bennett, Prognostic factors in cryptococcal meningitis. A study in 111 cases, Ann Intern Med, vol.80, issue.2, pp.176-81, 1974.

C. T. Dolan, Specificity of the latex-cryptococcal antigen test, Am J Clin Pathol, vol.58, issue.4, pp.358-64, 1972.

. Hay and D. W. Mackenzie, False positive latex tests for cryptococcal antigen in cerebrospinal fluid, J Clin Pathol, vol.35, issue.2, pp.244-249, 1982.

. Bennett and J. W. Bailey, Control for rheumatoid factor in the latex test for cryptococcosis, Am J Clin Pathol, vol.56, issue.3, pp.360-365, 1971.

W. H. Boom, . Piper, . Dj, K. L. Ruoff, . Ferraro et al., New cause for false-positive results with the cryptococcal antigen test by latex agglutination, J Clin Microbiol, vol.22, issue.5, pp.856-863, 1985.

C. K. Campbell, A. L. Payne, A. J. Teall, A. Brownell, . Mackenzie et al., Cryptococcal latex antigen test positive in patient with Trichosporon beigelii infection, Lancet, vol.2, issue.8445, pp.43-47, 1985.

S. J. Chanock, P. Toltzis, C. Wilson, and -. Cross, Reactivity between StomatococcusMucilaginosus and Latex Agglutination for Cryptococcal Antigen, Lancet, vol.342, issue.8879, pp.1119-1120, 1993.

L. B. Blevins, J. Fenn, H. Segal, P. Newcomb-gayman, . Carroll et al., False-positive cryptococcal antigen latex agglutination caused by disinfectants and soaps, J Clin Microbiol, vol.33, issue.6, pp.1674-1679, 1995.

J. R. Hamilton, . Noble, D. W. Denning, . Stevens, and . Da, Performance of cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatment, J Clin Microbiol, vol.29, issue.2, pp.333-342, 1991.

. Stamm, . Polt, and . Ss, False-negative cryptococcal antigen test, JAMA, vol.244, issue.12, p.1359, 1980.

. Gray and G. D. Roberts, Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen, J Clin Microbiol, vol.26, issue.11, pp.2450-2451, 1988.

. Stockman and G. D. Roberts, Corrected version specificity of the latex test for cryptococcal antigen: a rapid, simple method for eliminating interference factors, J Clin Microbiol, vol.17, issue.5, pp.945-952, 1983.

U. K. Frank, . Nishimura, . Sl, . Li, . Nc et al., Evaluation of an enzyme immunoassay for detection of cryptococcal capsular polysaccharide antigen in serum and cerebrospinal fluid, J Clin Microbiol, vol.31, issue.1, pp.97-101, 1993.

M. M. Leeflang, . Scholten, . Rj, A. W. Rutjes, J. B. Reitsma et al., Use of methodological search filters to identify diagnostic accuracy studies can lead to the omission of relevant studies, J Clin Epidemiol, vol.59, issue.3, pp.234-274, 2006.

J. G. Lijmer, . Mol, . Bw, S. Heisterkamp, . Bonsel et al., Empirical evidence of design-related bias in studies of diagnostic tests, JAMA, vol.282, issue.11, pp.1061-1067, 1999.

P. F. Whiting, A. W. Rutjes, . Westwood, . Me, S. Mallett et al., QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies, Ann Intern Med, vol.155, issue.8, pp.529-565, 2011.

D. Swinne, J. Bogaerts, P. Van-de-perre, J. Batungwanayo, and H. Taelman, Evaluation of the cryptococcal antigen test as a diagnostic tool of AIDS-associated cryptococcosis in Rwanda, Ann Soc Belg Med Trop, vol.72, issue.4, pp.283-291, 1992.

A. Sekhon, A. Garg, L. Kaufman, G. Kobayashi, Z. Hamir et al., Evaluation of a commercial enzyme immunoassay for the detection of cryptococcal antigen, Mycoses, vol.36, issue.1-2, pp.31-34, 1993.

R. J. Warren, A. Rceval, . Dwyer, and . Bw, Comparative evaluation of cryptococcal latex tests, Pathology, vol.25, issue.1, pp.76-80, 1993.

D. L. Jaye, . Waites, . Kb, B. Parker, S. L. Bragg et al., Comparison of two rapid latex agglutination tests for detection of cryptococcal capsular polysaccharide, Am J Clin Pathol, vol.109, issue.5, pp.634-675, 1998.

D. L. Kiska, . Orkiszewski, . Dr, D. Howell, . Gilligan et al., Evaluation of new monoclonal antibody-based latex agglutination test for detection of cryptococcal polysaccharide antigen in serum and cerebrospinal fluid, J Clin Microbiol, vol.32, issue.9, pp.2309-2320, 1994.

R. Negroni, C. Cendoya, A. I. Arechavala, A. M. Robles, M. Bianchi et al., Detection of Cryptococcus neoformans capsular polysaccharide antigen in asymptomatic HIVinfected patients, Rev Inst Med Trop Sao Paulo, vol.37, issue.5, pp.385-394, 1995.

J. Bogaerts, D. Rouvroy, H. Taelman, A. Kagame, M. A. Aziz et al., AIDSassociated cryptococcal meningitis in Rwanda (1983-1992): epidemiologic and diagnostic features, J Infect, vol.39, issue.1, pp.32-39, 1999.

T. Kantardjiev, A. Kouzmanov, T. Velinov, and E. Christozova, Latex agglutination test for diagnosis of the cryptococcal meningitis, Probl. Inf. Parasit. Dis, vol.28, issue.2, pp.25-26, 2000.

A. Wadhwa, R. Kaur, and P. Bhalla, Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections. The neurologist, vol.14, pp.247-251, 2008.

D. C. Saha, I. Xess, A. Biswas, D. M. Bhowmik, . Padma et al., Detection of Cryptococcus by conventional, serological and molecular methods, J Med Microbiol, vol.58, pp.1098-105, 2009.

J. N. Jarvis, S. Bauman, J. Pelfrey, G. Meintjes, . Williams et al., Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis, Clin Infect Dis, vol.53, issue.10, pp.1019-1042, 2011.

R. Marak, A. Jakhmola, U. Misra, A. Singh, A. Dixit et al., Central nervous cryptococcosis in Hiv and non-hiv patients a tertiary healthcare centre in Northern India, Mycoses, vol.54, p.101, 2011.

P. Escandon, J. Lizarazo, . Agudelo, . Ci, T. Chiller et al., Evaluation of a rapid lateral flow immunoassay for the detection of cryptococcal antigen for the early diagnosis of cryptococcosis in HIV patients in Colombia, Med Mycol, vol.51, issue.7, pp.765-773, 2013.

A. Lourens, . Jarvis, . Jn, G. Meintjes, . Samuel et al., Rapid diagnosis of cryptococcal meningitis by use of lateral flow assay on cerebrospinal fluid samples: influence of the high-dose "hook" effect, J Clin Microbiol, vol.52, issue.12, pp.4172-4177, 2014.

M. W. Tang, . Clemons, . Kv, D. A. Katzenstein, . Stevens et al., The cryptococcal antigen lateral flow assay: A point-of-care diagnostic at an opportune time, Crit Rev Microbiol, vol.42, issue.4, pp.634-676, 2016.

S. Kumari, . Verma, . Rk, D. P. Singh, and R. Yadav, Comparison of Antigen Detection and Nested PCR in CSF Samples of HIV Positive and Negative Patients with Suspected Cryptococcal Meningitis in a Tertiary Care Hospital, J Clin Diagn Res, vol.10, issue.4, pp.12-17, 2016.

S. N. Dharmshale, R. S. Bharadwaj, and K. , A, Cryptococcus meningitis and the genotypes of cryptococcus neoformans prevalent in Western Maharashtra, India. International Journal of Infectious Diseases, vol.45, issue.1, pp.311-312, 2016.

S. Chaurasia, . Waghmare, . As, A. Joshi, and S. Shivram, Biochemical Profile of Cerebrospinal Fluid (CSF) in Various Non-Tuberculous Cases of Meningitis in HIV Positive Patients, Indian Journal of Public Health Research and Development, vol.6, issue.2, pp.294-299, 2015.

R. Wahyuningsih, H. Herqutanto, R. Estiasari, T. Natriana, and N. Komari, Comparison between latex agglutination and lateral flow assay for the detection of Cryptococcus antigen in serum Mycoses, vol.57, pp.33-108, 2014.

S. M. Ignatyeva, . Bogomolova, . Ts, . Spiridonova, . Va et al., Pastorex Crypto Plus" test in complex diagnosis of cryptococcal meningitis in HIV-infected patients in Saint Petersburg, Mycoses, vol.56, issue.3, pp.55-167, 2013.

R. Marak, S. Kumari, . Misra, . Uk, J. Kalita et al., Rapid detection of cryptococcus from CSF by nested PCR in patients with clinically suspected cryptococcal meningitis in HIV and non-HIV patients, Mycoses, vol.55, issue.4, pp.95-338, 2012.

T. Asawavichienjinda, C. Sitthi-amorn, and V. Tanyanont, Serum cyrptococcal antigen: diagnostic value in the diagnosis of AIDS-related cryptococcal meningitis, J Med Assoc Thai, vol.82, issue.1, pp.65-71, 1999.

B. Calvo, O. Fischman, C. Filho, A. , R. Filho et al., Detection of capsular polysaccharide antigen of Cryptococcus neoformans in patients with AIDS and neurocryptococcosis in Sao Paulo, Brazil, Rev Inst Med Trop Sao Paulo, vol.33, issue.6, pp.485-90, 1991.

T. Kabanda, . Siedner, . Mj, . Klausner, . Jd et al., Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid, Clin Infect Dis, vol.58, issue.1, pp.113-119, 2014.

M. R. Nelson, M. Bower, . Smith, C. Reed, D. Shanson et al., The value of serum cryptococcal antigen in the diagnosis of cryptococcal infection in patients infected with the human immunodeficiency virus, J Infect, vol.21, issue.2, pp.175-81, 1990.

D. A. Williams, T. Kiiza, R. Kwizera, R. Kiggundu, S. Velamakanni et al., Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study, Clin Infect Dis, vol.61, issue.3, pp.464-471, 2015.

J. N. Jarvis, T. Bicanic, A. Loyse, D. Namarika, A. Jackson et al., Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes, Clin Infect Dis, vol.58, issue.5, pp.736-781, 2014.

T. Bicanic, C. Bottomley, A. Loyse, A. E. Brouwer, C. Muzoora et al., Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIVAssociated Cryptococcal Meningitis, Antimicrob Agents Chemother, vol.59, issue.12, pp.7224-7255, 2015.

S. Molloy, C. Kanyama, R. Heyderman, A. Loyse, C. Kouanfack et al., A randomized controlled trial for the treatment of HIV-associated cryptococcal meningitis in Africa: oral fluconazole plus flucytosine or one week amphotericin-based therapy versus two weeks amphotericin-based therapy. The ACTA Trial, Journal of the International AIDS Society, vol.20, pp.105-105, 2017.

H. A. Gallis, R. H. Drew, W. W. Pickard, and B. Amphotericin, 30 years of clinical experience, Rev Infect Dis, vol.12, issue.2, pp.308-337, 1990.

. Tassel and M. A. Madoff, Treatment of Candida sepsis and Cryptococcus meningitis with 5-fluorocytosine. A new antifungal agent, Jama, vol.206, issue.4, pp.830-832, 1968.

J. N. Day, . Chau, . Tt, M. Wolbers, . Mai et al., Combination antifungal therapy for cryptococcal meningitis, N Engl J Med, vol.368, issue.14, pp.1291-302, 2013.

T. Bicanic, R. Wood, G. Meintjes, R. , K. Brouwer et al., High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIVinfected patients: a randomized trial, Clin Infect Dis, vol.47, issue.1, pp.123-153, 2008.

B. Aguirre and R. Hamid, AM, Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function, Cochrane Database Syst Rev, issue.11, p.10481, 2015.

R. J. Hamill, J. D. Sobel, W. El-sadr, . Johnson, . Pc et al., Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, doubleblind clinical trial of efficacy and safety, Clin Infect Dis, vol.51, issue.2, pp.225-257, 2010.

J. Mora-duarte, R. Betts, C. Rotstein, A. L. Colombo, L. Thompson-moya et al., Comparison of caspofungin and amphotericin B for invasive candidiasis, N Engl J Med, vol.347, issue.25, pp.2020-2029, 2002.

A. Safdar, J. Ma, F. Saliba, B. Dupont, J. R. Wingard et al., Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis. Medicine (Baltimore), vol.89, pp.236-280, 2010.

E. J. Anaissie, . Darouiche, . Ro, D. Abi-said, O. Uzun et al., Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature, Clin Infect Dis, vol.23, issue.5, pp.964-72, 1996.

R. Herbrecht, . Denning, . Dw, . Patterson, . Tf et al., Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis, N Engl J Med, vol.347, issue.6, pp.408-423, 2002.

U. Health and H. Services, Division of AIDS. Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 2.0, 1923.